Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,763.96
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
102.95
(
-1.42%
)
Bitcoin
70,380.01
(
0.69%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 85426

Tuesday, 10/27/2009 6:55:44 PM

Tuesday, October 27, 2009 6:55:44 PM

Post# of 257262
Re: VX-813/VX-985

It’s reasonable to infer that the second-gen protease inhibitors, VX-813 and VX-985 are effectively dead.

Why would VRTX drop the second-gen PIs? Is VRTX just naive and thinking that telaprevir can't be improved upon to a much greater degree or, what I assume, does VRTX just not believe that these two compounds do not improve upon telaprevir enough coupled with the fact that they're so far behind?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now